Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00967473 · ClinicalTrials.gov registry record · NA
ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)
A NA study of Bilateral Cataract, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00967473 is a NA study of Bilateral Cataract that has completed, run by Alcon Research. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00967473, a NA study of Bilateral Cataract, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to describe rates of spatial distortions related to intraocular lens (IOL) misalignment for ACRYSOF® Single-Piece Toric NATURAL IOL Model SN60T9 when implanted bilaterally into the capsular bag following phacoemulsification in adult patients with bilateral cataract and regular corneal astigmatism. Subjects were implanted with the Model SN60T9 in the first operative (study) eye and either Model SN60T9 or Model SN60T8 in the second operative eye.
Conditions Studied
Interventions
- DEVICE ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8.
Study Locations (1)
Texas
- Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00967473
The ClinicalTrials.gov registry entry for NCT00967473 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bilateral Cataract appearing as the primary indexed condition, and to 1 intervention - of which ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8. is the first listed.
NCT00967473 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00967473 about?
NCT00967473 is a clinical study titled "ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)". The purpose of this study is to describe rates of spatial distortions related to intraocular lens (IOL) misalignment for ACRYSOF® Single-Piece Toric NATURAL IOL Model SN60T9 when implanted bilaterally into the capsular bag following phacoemulsification in adult patients with bilateral cataract and r...
What is the current status of trial NCT00967473?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2009-08. Estimated completion is 2010-05.
What conditions does trial NCT00967473 study?
This clinical trial studies the following conditions: Bilateral Cataract.
What interventions are being tested in trial NCT00967473?
The interventions under investigation include: ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8. (DEVICE).
Who is sponsoring clinical trial NCT00967473?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00967473 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.